Articles tagged with Chronic Obstructive Pulmonary Disease
Researchers discovered neuromedin B, a nervous system protein, prevents overactive immune responses and damaging inflammation in diseases like asthma, allergies, and COPD. The study provides hope for possible treatments using NMB to treat inflammatory diseases.
Researchers identified lung-related factors associated with increased hip fracture risk in smokers, including emphysema and COPD exacerbations. These findings suggest that osteoporosis screening and management decisions should consider lung health in at-risk patients.
Researchers at University of Huddersfield found that the benefits of using inhalers and nebulisers containing steroids outweigh the risks despite COVID-19 concerns. The study confirms that patients with asthma or COPD can continue using their regular medicines, including steroids.
Researchers discovered a link between small airways and increased COPD risk in non-smokers. People with smaller airways relative to their lungs may have lower breathing capacity, making them more susceptible to COPD.
A new study found that people with small airways relative to their lungs' volume are at increased risk of chronic obstructive pulmonary disease (COPD) regardless of smoking habits. Individuals with smaller airways had the poorest lung function and were 8 times more likely to develop COPD.
A compact sensor system using modified carbon nanotubes detects high concentrations of nitrogen dioxide in exhaled air, indicating chronic obstructive pulmonary disease (COPD) or other respiratory issues. The device's sensitivity is shown to detect biomarkers for specific diseases, including lung cancer and asthma.
A study of nearly 200,000 Medicare patients found that starting pulmonary rehabilitation within 90 days of COPD hospitalization significantly improves one-year survival. Pulmonary rehabilitation combines exercise training and self-management education.
A new study has found that people with chronic obstructive pulmonary disease (COPD) and smokers are at a higher risk of severe complications and mortality from COVID-19. Researchers analyzed data from over 2,500 patients with COVID-19 and found that COPD was associated with a 63% risk of severe disease and a 60% risk of mortality.
A study published in the Journal of American Biomedical Science & Research found that higher doses of statins and long-acting inhalers for chronic obstructive pulmonary disease may not provide significant benefits for most patients, given the costs and risks involved.
The study suggests that women have a lower threshold for seeking primary healthcare compared to men, with older women living longer with disabling conditions. This difference may be due to various factors such as fear of diagnosis or differences in symptom recognition.
Abnormal stem cells in COPD patients drive key features of the disease, including mucins that block airways and fibrosis and inflammation. Researchers have identified specific cells responsible for COPD pathology and are screening them against drug libraries to discover new treatments.
The American Thoracic Society recommends LABA/LAMA combination therapy for COPD patients experiencing dyspnea or exercise intolerance. This guideline also suggests considering triple therapy and withdrawing inhaled corticosteroids if no exacerbations occur.
A study published in the European Respiratory Journal found that people with COPD and smokers have higher levels of ACE-2, a molecule that allows coronavirus to infect lung cells. Former smokers had similar levels of ACE-2 as non-smokers, highlighting the importance of quitting smoking to protect against COVID-19.
Research published in Thorax journal found a heightened risk of lung cancer in people with COPD who have never smoked. The risk is comparable to that of smokers without chronic lung disease, suggesting early detection may reduce treatment complications.
A new study published in the American Journal of Respiratory and Critical Care Medicine reports that a three-drug combination of fluticasone furoate, umeclidinium, and vilanterol reduces all-cause mortality by 42% in patients with chronic obstructive pulmonary disease (COPD) treated with an inhaler once daily.
A UK study emphasizes the significance of spirometry in identifying chronic obstructive pulmonary disease (COPD), particularly among patients with respiratory symptoms. The study found that over-reliance on radiological changes alone may lead to incorrect diagnoses, highlighting the need for comprehensive assessments.
A recent study published in Arthritis & Rheumatology found that asthma and chronic obstructive pulmonary disease (COPD) are associated with a higher risk of developing rheumatoid arthritis. Women with asthma were 53% more likely to develop rheumatoid arthritis, while those with COPD were 89% more likely.
Researchers found that daily meetings among healthcare providers can significantly shorten hospital stays for COPD patients. Integrated care conferences (ICCs) resulted in an average length of stay reduction of 3.18 days compared to hospitals without ICCs.
A new study published in the Annals of the American Thoracic Society has found that traditional biomass stoves significantly increase indoor levels of harmful PM2.5 and carbon monoxide, leading to lung inflammation and potentially chronic obstructive pulmonary disease (COPD) in developing nations.
A randomized controlled trial shows that lay health coaching can significantly improve inhaler use among low-income COPD patients, with 40% of health-coached patients demonstrating effective use of their inhalers. The intervention also improved inhaler technique, contributing to long-term COPD outcomes.
People living with HIV in Ontario have a 34% higher incidence rate of COPD, diagnosed at 50 years old vs. 62 for HIV-negative individuals, according to a study led by St. Michael's Hospital researchers. The study also found that women with HIV have a 54% higher risk of COPD.
In a new study, Mayo Clinic researchers discovered that in-home bilevel positive airway pressure (BiPAP) therapy can significantly improve COPD patient outcomes, including reduced mortality rates and fewer hospital admissions. The treatment helps alleviate shortness of breath and reduces the risk of intubation.
Researchers at the University of Sheffield have identified a class of cancer drugs that accelerate neutrophil cell death and promote healing in the lungs. This breakthrough could lead to the development of effective treatments for chronic obstructive pulmonary disease (COPD), which affects millions worldwide.
A new educational outreach training package has shown effectiveness in managing respiratory diseases like COPD and asthma in Brazil. The Practical Approach to Care Kit (PACK) provides basic, cost-effective ways to diagnose and treat these common, severe diseases.
A pharmacy service has been shown to reduce NHS costs by £651 million while improving patient outcomes through enhanced medication adherence. The New Medicine Service, delivered by pharmacists since 2011, supports patients taking new medicines and helps them adhere to their treatment regimens.
Global COPD death rates declined between 1995 and 2017, but the total number of deaths increased as aging populations contributed to rising mortality. Measures to reduce exposure to risk factors, such as tobacco control policies, have had a positive effect on reducing overall COPD death rates.
Researchers have proposed new diagnostic criteria for chronic obstructive pulmonary disease (COPD) that include environmental exposure, symptoms and abnormal CT scans. The criteria may help identify an additional 2-5 million people with COPD, leading to better care and potential research into slowing or preventing the disease.
New research reveals that the shape and architecture of collagen and elastin fibers in lungs affects their elasticity. Crimped fibers exhibit greater flexibility, while straight fibers are stiffer.
A study published in JAMA found that patients with limited English proficiency are more likely to experience hospital readmissions and return emergency department visits. The observational study examined two Toronto hospitals and found that those with limited proficiency were more prone to complications and required additional care.
An observational study found a significant association between workplace exposure to disinfectants and cleaning products and an increased risk of new COPD cases among female nurses. The study highlights the need for better ventilation and protective measures in workplaces to mitigate this risk.
A new study led by Columbia University researchers found that people who smoke just a few cigarettes a day can still experience long-term lung damage. The study also showed that the rate of decline in lung function among light smokers is closer to that of heavy smokers than previously thought.
A new analysis of two international clinical trials predicts that benralizumab may be effective for a subpopulation of patients with moderate to very severe COPD who have elevated blood eosinophil counts and a history of frequent exacerbations. The study found no significant efficacy in reducing annual COPD exacerbation rates for patie...
A new technique uses nanoparticles to measure how quickly they move through mucus samples, correlating with COPD severity. The study's findings suggest that the structure of mucus in patients with severe COPD may be distinct and affect particle movement.
A smart shirt has proven to be accurate in measuring breathing, with results similar to traditional equipment, according to European Respiratory Society research. The Hexoskin senses chest movements and records air volume, heart rate, and movement, making it a practical alternative for monitoring lung function.
A study found that older adults with chronic obstructive pulmonary disease (COPD) are twice as likely to use prescription synthetic oral cannabinoids compared to those without COPD. This raises concerns about the potential dangers associated with this medication class, particularly in subgroups at heightened risk for adverse events.
A new study found that using a CRP finger-prick blood test reduced antibiotic use by 20% in people with COPD flare-ups without affecting recovery or well-being. This approach may help tackle antibiotic resistance.
A massive study of over 300,000 people found that air pollution significantly reduces lung function and increases the risk of developing COPD. Exposure to high levels of particulate matter and nitrogen dioxide was linked to lung aging equivalent to two years of aging.
Researchers analyzed data from a large, multi-ethnic sample and found that the 0.70 threshold provided discrimination of COPD-related hospitalization and mortality comparable to other fixed thresholds. The study supports the continued use of FEV1/FVC <0.70 to identify individuals at risk of clinically significant COPD.
A new NIH-funded study supports a 70% ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) as an accurate threshold for diagnosing clinically significant airflow obstruction in COPD. This simple approach may lead to earlier detection and treatment, improving patient care and public health.
Good heart and lung fitness in middle age is associated with a lower long-term risk of chronic lung disease (COPD). Physical activity boosts fitness may delay development, progression, and death from COPD. Studies have suggested that high physical activity levels are associated with reduced COPD risk.
Researchers found that electronic inhaler monitoring, combined with a disease management program, reduced healthcare utilization in patients with COPD. The study showed a significant reduction in COPD-related hospitalizations and ER visits, from an average of 3.4 to 2.2 trips per year.
A unique case of a chest cavity fire during emergency heart surgery was presented at the Euroanaesthesia Congress. The incident occurred when supplemental oxygen leaked from a ruptured lung, causing a spark from an electrocautery device to ignite a dry surgical pack.
A joint ATS and European Respiratory Society statement reveals that occupational hazards contribute to over 1 in 10 cases of non-cancerous lung diseases, including asthma and COPD. The study estimates the burden of these conditions, highlighting a need for policy makers to prioritize prevention among working women and men worldwide.
A new study from the University of British Columbia found that steroid inhalers can lower lung cancer risk in COPD patients. The research, published in European Respiratory Journal, analyzed data from 39,676 adults with COPD and found a 25-30% reduction in lung cancer risk among those using steroids.
Research suggests that high-deductible insurance plans can lead to delayed medication dosages and hospitalizations among COPD patients. Patients with high deductibles are more likely to forgo needed healthcare due to financial constraints.
Research using SPIROMICS data shows women with COPD report more severe symptoms, including acute exacerbations, and lower quality of life than men. The study aims to investigate the role hormonal factors may play in these gender differences.
Research at ATS 2019 reveals a significant disparity in pulmonary rehabilitation participation among African American patients with COPD compared to their white counterparts. Pulmonary rehabilitation has been shown to improve life expectancy and reduce exacerbations from the disease.
A web-based intervention that included physical activity goals, disease self-management education, and a community forum reduced the risk of acute exacerbation in COPD patients. The reduction in exacerbations occurred despite no significant increase in physical activity levels compared to those receiving only a pedometer.
A recent study published in the New England Journal of Medicine found that benralizumab, an asthma drug, was ineffective in reducing exacerbations in patients with moderate to very severe COPD. The study involved over 3,000 patients and showed no significant decrease in COPD exacerbation rates among those receiving benralizumab.
Research presented at ATS 2019 reveals that younger generations of coal miners are more susceptible to deaths from black lung disease and chronic obstructive pulmonary disease (COPD) compared to older generations. This trend suggests a potential increase in respiratory health risks among younger workers.
A new study by Intermountain Healthcare introduces the Summit Score, a computer-calculated system that predicts COPD patient outcomes with higher accuracy. The score takes into account various risk factors and can help doctors plan and administer better patient care.
A new laboratory-based method, LIVE score, predicts outcomes for COPD patients and identifies those at high risk of death or disease advancement. The study found that patients with high-risk scores had the highest one-year mortality rates and palliative care referrals.
Researchers are conducting a multi-center study to determine which medication, azithromycin or roflumilast, is more effective in reducing the risk of death and hospitalization in people with COPD. The clinical trial will enroll over 3,000 patients at 30 centers across the US.
Researchers have found that smokers with COPD have significant unmet mental health care needs, particularly anxiety and depressive symptoms. These symptoms can impact many COPD-related outcomes, including hospital readmissions and exacerbations.
A randomized trial found that adding azithromycin to standard care reduced treatment failure rates by 49% and improved hospital stay durations. Non-smokers showed significant benefits, while current smokers experienced little improvement.
Research highlights the association between chronic obstructive pulmonary disease (COPD) and type 2 diabetes, emphasizing the importance of collaborative care to address underlying systemic inflammation. Achieving optimal glucose control is crucial in patients with coexistent T2 DM and COPD.
Research reveals that exposure to biomass fuel is a major contributor to COPD in nonsmokers, particularly in rural populations. The study found that 61% of patients lived in rural areas and had exposure to biomass gas, highlighting the need for further research into this subset of nonsmokers with COPD.
A new study by Australian researchers has discovered that dietary fiber reduces lung inflammation and damage, improving lung function. The findings suggest that consuming high amounts of fiber may help prevent chronic obstructive pulmonary disease (COPD), a condition affecting 1 in 7 Australians over the age of 40.
Researchers analyzed 215,000 ED visits to find disparities in transfers based on insurance status. Uninsured and Medicaid patients faced higher risk of transfer compared to privately insured patients, with uninsured patients more likely to be discharged.
A non-invasive imaging biomarker called Parametric Response Mapping (PRM) can identify small airway damage in Chronic Obstructive Pulmonary Disease (COPD). This technique measures lung density during inhalation and exhalation, helping to predict patients who will lose lung function.